Two individuals reviewing information on a tablet.

Investigator Sponsored Studies

Kura Oncology’s Investigator Sponsored Studies (ISS) Program and our partners provides funding and/or clinical supplies to eligible applicants to help address legitimate medical or scientific questions affecting the use of Kura Oncology’s investigational compounds.

Areas of interest

How to submit your application

  • ISS submission requirements include

    Please submit these files to . Following review of the initial submission, a full protocol and final study budget will be requested. Applicants will be updated on the status of their initial application upon receipt. All approved submissions are considered conditional until a finalized written agreement.

    For more information or questions please contact .

    To request a medical science liaison please contact .

    For investigators located outside the United States interested in submitting an Investigator-Initiated Study (IIS) proposal involving ziftomenib, please contact Kyowa Kirin Global Medical Affairs at: .